Work

Cannabis craving and cross-substance substitution during cannabis treatment: Initial insights across seven cannabis use disorder clinical trials

Year: 2026

Type: article

Source: Addictive Behaviors

DOI: 10.1016/j.addbeh.2026.108834

Authors: Morgan A. Douglass, Gaylen E. Fronk, Nathaniel Baker, Aimee L. McRae-Clark, Kevin M. Gray, Elizabeth J. Santa Ana, Rachel L. Tomko, Brian Neelon, Erin A. McClure

Institutions: Medical University of South Carolina, University of Colorado Anschutz, MUSC Hollings Cancer Center, Ralph H. Johnson VA Medical Center

Language: English

Topic: Substance Abuse Treatment and Outcomes

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Institute on Drug Abuse, National Center for Advancing Translational Sciences

Awards: Advancing Varenicline as a Treatment for Cannabis Use Disorder, Buspirone Treatment for Marijuana Dependence, Characterization of salivary hormones in freely cycling smokers and the relationship between dynamic patterns in hormone levels and smoking behavior, N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder, Advancing Varenicline as a Treatment for Cannabis Use Disorder, A Controlled Trial of N-Acetylcysteine (NAC) in Cannabis Dependent Adolescents, Vilazodone treatment for marijuana dependence, South Carolina Clinical & Translational Research Institute (SCTR), Quantifying data-driven metrics of meaningful cannabis reduction, Multidisciplinary Research Training in Palliative Care, Southern Consortium Node of the Clinical Trials Network

OpenAlex ID: W7202293780

FWCI:

Cites: 47

Cited by:

Related to: 10